Celgene cancer drug clinical trial suspended - WSJ (Reuters


Reuters - A clinical trial of Celgene Corp.'s
experimental cancer drug, Revlimid, has been suspended because
of concerns about blood clots, the Wall Street Journal reported
on Wednesday.